Vanguard Group
SER icon

Vanguard Group’s Serina Therapeutics SER Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$928K Buy
150,623
+85,290
+131% +$525K ﹤0.01% 3764
2025
Q1
$370K Buy
65,333
+3,260
+5% +$18.5K ﹤0.01% 3949
2024
Q4
$311K Buy
62,073
+17,573
+39% +$88K ﹤0.01% 4040
2024
Q3
$298K Buy
44,500
+22,368
+101% +$150K ﹤0.01% 4078
2024
Q2
$212K Buy
22,132
+2,181
+11% +$20.9K ﹤0.01% 4160
2024
Q1
$269K Sell
19,951
-681,804
-97% -$9.18M ﹤0.01% 4127
2023
Q4
$270K Buy
701,755
+3,341
+0.5% +$1.29K ﹤0.01% 4176
2023
Q3
$475K Hold
698,414
﹤0.01% 4064
2023
Q2
$624K Hold
698,414
﹤0.01% 4058
2023
Q1
$463K Hold
698,414
﹤0.01% 4142
2022
Q4
$385K Sell
698,414
-1,450
-0.2% -$800 ﹤0.01% 4171
2022
Q3
$393K Hold
699,864
﹤0.01% 4281
2022
Q2
$403K Sell
699,864
-1,156
-0.2% -$666 ﹤0.01% 4338
2022
Q1
$599K Buy
701,020
+200
+0% +$171 ﹤0.01% 4352
2021
Q4
$764K Hold
700,820
﹤0.01% 4337
2021
Q3
$659K Buy
700,820
+8,943
+1% +$8.41K ﹤0.01% 4334
2021
Q2
$1.07M Hold
691,877
﹤0.01% 4138
2021
Q1
$1.12M Buy
691,877
+45,155
+7% +$73.2K ﹤0.01% 3985
2020
Q4
$983K Buy
646,722
+10,915
+2% +$16.6K ﹤0.01% 3832
2020
Q3
$515K Sell
635,807
-10,226
-2% -$8.28K ﹤0.01% 3808
2020
Q2
$611K Sell
646,033
-83,151
-11% -$78.6K ﹤0.01% 3724
2020
Q1
$678K Sell
729,184
-1,497
-0.2% -$1.39K ﹤0.01% 3601
2019
Q4
$1.33M Sell
730,681
-2,875
-0.4% -$5.23K ﹤0.01% 3559
2019
Q3
$1.44M Buy
733,556
+30,953
+4% +$60.7K ﹤0.01% 3551
2019
Q2
$2.58M Buy
702,603
+197,076
+39% +$723K ﹤0.01% 3398
2019
Q1
$2.05M Buy
505,527
+32,285
+7% +$131K ﹤0.01% 3442
2018
Q4
$1.42M Buy
+473,242
New +$1.42M ﹤0.01% 3466